On January 9, 2025, Tiansheng Pharmaceutical Group Co.,Ltd. (ST Tiansheng, stock code: 002872) announced that the company, its controlling shareholder, and actual controller received investigation notices from the China Securities Regulatory Commission (CSRC). The CSRC has decided to initiate investigations into the company, its controlling shareholder, and actual controller for suspected violations of information disclosure regulations.
According to the Civil Code, Securities Law, and the Supreme People's Court's judicial interpretations regarding civil compensation for false statements, listed companies, controlling shareholders, actual controllers, directors, supervisors, senior management, and intermediary institutions shall bear civil compensation liability for securities fraud such as false statements that cause damage to securities investors' rights and interests. The scope of compensation includes: investment losses, commissions, stamp taxes, and interest losses. Securities investors whose rights and interests have been damaged may file civil compensation lawsuits with competent courts.
Due to Tiansheng Pharmaceutical Group Co.,Ltd.'s suspected violations of information disclosure regulations and the CSRC's investigation, lawyer Song Yixin from Shanghai Hanlian Law Firm is soliciting litigation representation for securities investors who previously purchased Tiansheng Pharmaceutical Group Co.,Ltd. shares, representing investors in compensation lawsuits. Investors whose rights and interests have been damaged may register for compensation claims with the aforementioned lawyer.
Lawyer Song Yixin believes that the compensation conditions for the Tiansheng Pharmaceutical Group Co.,Ltd. case are: investors who purchased Tiansheng Pharmaceutical Group Co.,Ltd. stocks, bonds, or other publicly issued securities market products before January 9, 2025, and sold or continue to hold them on or after January 9, 2025, may register for compensation claims.
**Lawyer's Reminders and Explanations for This Case:**
1. The above compensation conditions are for reference only and do not involve any securities investment decisions or securities trading recommendations for investors. The final compensation conditions will be further adjusted based on the conclusions of the CSRC's administrative penalties and shall be subject to the legal time points, compensation recipients, compensation scope, compensation standards, and accounting calculation methods recognized by the final effective judgments of relevant courts.
2. After the cancellation of the prerequisite characterized by administrative penalty decisions, although investors can file lawsuits directly, due to limited investigative means, filing lawsuits directly based on investigation notices or administrative regulatory measures carries the risk of losing the case. Therefore, as a professional lawyer, I remind investors that administrative penalty decisions should still be considered as one of the necessary prerequisites for filing lawsuits.
3. In the proposed civil tort litigation cases, whether the listed company is delisted or not does not affect the process of civil compensation tort litigation, but may affect the litigation progress. However, entering bankruptcy procedures (including reorganization, pre-reorganization, or liquidation) may have a greater impact on litigation progress. If representative litigation occurs, you may choose to participate or not participate, join or withdraw.
4. Investor compensation registration or pre-registration should provide the following materials: (1) Copy of ID card. (2) Original "Securities Account Opening Information Confirmation" (stamped with securities company business department seal). (3) Original "Securities Transaction Record Statement" from the first purchase of the stock/bond/warrant to present (stamped with securities company business department seal).
This article is provided by lawyer Song Yixin from Shanghai Hanlian Law Firm. Lawyer Song Yixin has been practicing law since 1992 and is currently a partner at Shanghai Hanlian Law Firm. His service areas mainly include legal services for capital markets, securities markets, and financial markets, as well as protection of investor/financial consumer rights and interests. Since beginning practice, he has provided legal services for over 10,000 securities litigation or shareholder dispute cases. He has authored books including "Securities Law Principles and Practice," "Securities Civil Compensation Practice Manual," "Stock Market Rights Protection," "Compilation of Judicial Judgment Documents in Chinese Securities Civil Compensation Cases," and "Directors' Liability Insurance and Investor Rights Protection." Practice License Number: 13101199210628065.